FDA Approves Lumryz (sodium oxybate) for Cataplexy or ExcessiveDaytime Sleepiness in Adults with Narcolepsy
May 1, 2023FDA Approves Arexvy (respiratory syncytial virus vaccine, adjuvanted) Respiratory Syncytial Virus (RSV) Vaccine for Older Adults
May 3, 2023A new Cedars-Sinai AI tool may help predict the chance of adverse cardiac events and show how a patient’s risk for these events can change over time.
By Shania Kennedy
May 02, 2023 - Cedars-Sinai researchers have developed an artificial intelligence (AI) tool that can predict a patient’s chance of adverse cardiac events, such as a heart attack, and demonstrate how that patient’s risk may change over time, according to a study published this week in npj Digital Medicine.
According to a press release detailing the study’s findings, the AI tool could help provide patients with personalized risk assessments and insights into their heart health.
"Using a specific type of AI trained to interpret images of the heart and developed at Cedars-Sinai, we could both predict the chance of cardiac events—like death, heart attack, or the need for urgent treatment of the heart vessels—and show how the likelihood of these adverse events changes over time," explained Piotr Slomka, PhD, director of Innovation in Imaging at Cedars-Sinai and a research scientist in the Division of Artificial Intelligence in Medicine and the Smidt Heart Institute.